Integration of Molecular Docking and In Vitro Studies: A Powerful Approach for Drug Discovery in Breast Cancer
Molecular docking in the pharmaceutical industry is a powerful in silico approach for discovering novel therapies for unmet medical needs predicting drug–target interactions. It not only provides binding affinity between drugs and targets at the atomic level, but also elucidates the fundamental phar...
Main Authors: | Claudia Cava, Isabella Castiglioni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/10/19/6981 |
Similar Items
-
Applications of molecular docking in natural products-based drug discovery
by: Isaac Asiamah, et al.
Published: (2023-07-01) -
Molecular modeling in drug discovery
by: Temitope Isaac Adelusi, et al.
Published: (2022-01-01) -
Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer
by: Md Shahin Alam, et al.
Published: (2022-09-01) -
Novel Group of AChE Reactivators—Synthesis, In Vitro Reactivation and Molecular Docking Study
by: David Malinak, et al.
Published: (2018-09-01) -
A Molecular Docking Study of Human STEAP2 for the Discovery of New Potential Anti-Prostate Cancer Chemotherapeutic Candidates
by: Timothy Ongaba, et al.
Published: (2022-05-01)